These discriminators were validated comparing TTR‐FAP patients with a cohort of patients with chemotherapy‐induced polyneuropathy (CIN) and chronic inflammatory demyelinating neuropathy (CIDP). Here, FAP is linked to chronic inflammatory demyelinating polyradiculoneuropathy.